Medical Management of Infliximab Failure in Acute Severe Ulcerative Colitis
| Errataetall: |
CommentOn: J Crohns Colitis. 2019 Sep 19;13(9):1105-1110. - PMID 30726894 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Journal of Crohn's & colitis - 14(2020), 7 vom: 30. Juli, Seite 1029 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nicolaides, Steven [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 09.07.2021 Date Revised 12.07.2021 published: Print CommentOn: J Crohns Colitis. 2019 Sep 19;13(9):1105-1110. - PMID 30726894 Citation Status MEDLINE |
|---|
| doi: |
10.1093/ecco-jcc/jjaa006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305289268 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305289268 | ||
| 003 | DE-627 | ||
| 005 | 20231225120842.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ecco-jcc/jjaa006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1017.xml |
| 035 | |a (DE-627)NLM305289268 | ||
| 035 | |a (NLM)31930284 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nicolaides, Steven |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Medical Management of Infliximab Failure in Acute Severe Ulcerative Colitis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.07.2021 | ||
| 500 | |a Date Revised 12.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: J Crohns Colitis. 2019 Sep 19;13(9):1105-1110. - PMID 30726894 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Infliximab |2 NLM | |
| 650 | 7 | |a B72HH48FLU |2 NLM | |
| 700 | 1 | |a Vasudevan, Abhinav |e verfasserin |4 aut | |
| 700 | 1 | |a Van Langenberg, Daniel R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Crohn's & colitis |d 2007 |g 14(2020), 7 vom: 30. Juli, Seite 1029 |w (DE-627)NLM204021901 |x 1876-4479 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2020 |g number:7 |g day:30 |g month:07 |g pages:1029 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ecco-jcc/jjaa006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2020 |e 7 |b 30 |c 07 |h 1029 | ||